September 22, 2023 Comments Off on New patent for Astrazeneca drug LOKELMA Posted in: Patent Added Annual Drug Patent Expirations for LOKELMA Lokelma is a drug marketed by Astrazeneca and is included in one NDA. It is available from two suppliers. There are thirteen patents protecting…
The post New patent for Astrazeneca drug LOKELMA appeared first …
September 22, 2023 Comments Off on New patent for Tarsus drug XDEMVY Posted in: Patent Added Annual Drug Patent Expirations for XDEMVY Xdemvy is a drug marketed by Tarsus and is included in one NDA. It is available from one supplier. The generic ingredient in XDEMVY…
The post New patent for Tarsus drug XDEMVY appeared first on DrugPatentWatch …
